Factors associated with poor therapeutic response to multiple biologic agents in psoriasis are not well-studied.Female sex, hyperlipidemia, Medicaid insurance, earlier year of biologic initiation, decreased psoriasis duration, and prior non-biologic systemic therapy use were associated with multiple biologic failure. These…

Continue Reading